TORONTO, October 2, 2018 – Join this live webinar upcoming on Wednesday, October 10, 2018, at 10 a.m. EDT (3 p.m. BST/UK) to learn how to correctly classify clinical studies as interventional or non-interventional.
When speaking about interventional vs. non-interventional clinical study, the terminology used by methodologists and regulatory professionals differs, this can lead to confusion. Since misclassification can have a significant impact on study design and conduct, it’s important to find a common understanding between the terminology used to describe a study and the meaning behind those terms.
Featured speakers Stuart McCully, Ph.D. (UK), Vice President of Regulatory Advisory Services at RWLP and David Thompson, Ph.D., Sr. Vice President of Real World Evidence Advisory at Syneos Health will discuss how regulatory classification drives study start-up, operational requirements and the costs incurred. They will also discuss whether the use of technology and connected devices impact study classification.
For more information about this complimentary webinar visit: Interventional vs. Non-Interventional: Considerations for Correctly Classifying Your Clinical Trial.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food, and medical device community. Every year thousands of industry practitioners (from life science, food, and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends, and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar
Tel: +1 (416) 977-6555 ext 352
Email: [email protected]
Powered by WPeMatico